BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7449762)

  • 1. Correlation of enzymatic activity and anticoagulant properties of phospholipase A2.
    Verheij HM; Boffa MC; Rothen C; Bryckaert MC; Verger R; de Haas GH
    Eur J Biochem; 1980 Nov; 112(1):25-32. PubMed ID: 7449762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulant effect of myotoxic phospholipase A2 isolated from the venom of the snake Bothrops asper (Viperidae).
    Alvarado J; Gutiérrez JM
    Rev Biol Trop; 1988 Nov; 36(2B):563-5. PubMed ID: 3273606
    [No Abstract]   [Full Text] [Related]  

  • 3. Snake venom phospholipases A2. A fluorescence study of their binding to phospholipid vesicles correlation with their anticoagulant activities.
    Prigent-Dachary J; Boffa MC; Boisseau MR; Dufourcq J
    J Biol Chem; 1980 Aug; 255(16):7734-9. PubMed ID: 7400142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of anticoagulant and procoagulant properties of 28 snake venoms from families Elapidae, Viperidae, and purified Russell's viper venom-factor X activator (RVV-X).
    Suntravat M; Nuchprayoon I; Pérez JC
    Toxicon; 2010 Sep; 56(4):544-53. PubMed ID: 20677373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolytic and anticoagulant study of the neurotoxin vipoxin and its components--basic phospholipase A2 and an acidic inhibitor.
    Atanasov VN; Danchev D; Mitewa M; Petrova S
    Biochemistry (Mosc); 2009 Mar; 74(3):276-80. PubMed ID: 19364321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibition of clotting complexes of the extrinsic coagulation cascade by the phospholipase A2 isoenzymes from Naja nigricollis venom.
    Stefansson S; Kini RM; Evans HJ
    Thromb Res; 1989 Aug; 55(4):481-91. PubMed ID: 2814939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of carboxylate group modification on enzymatic and cardiotoxic properties of snake venom phospholipases A2.
    Barrington PL; Condrea E; Soons KR; Yang CC; Rosenberg P
    Toxicon; 1984; 22(5):743-58. PubMed ID: 6523504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of modification of one histidine residue on the enzymatic and pharmacological properties of a toxic phospholipase A2 from Naja nigricollis snake venom and less toxic phospholipases A2 from Hemachatus haemachatus and Naja atra snake venoms.
    Condrea E; Fletcher JE; Rapuano BE; Yang CC; Rosenberg P
    Toxicon; 1981; 19(1):61-71. PubMed ID: 7222090
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of a relatively toxic phospholipase A2 from Naja nigricollis snake venom with that of a relatively non-toxic phospholipase A2 from Hemachatus haemachatus snake venom--II. Pharmacological properties in relationship to enzymatic activity.
    Fletcher JE; Rapuano BE; Condrea E; Yang CC; Ryan M; Rosenberg P
    Biochem Pharmacol; 1980 Jun; 29(11):1565-74. PubMed ID: 7396987
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of Russell's viper venom phospholipase A on blood coagulation and platelet aggregation.
    Teng CM; Chen YH; Ouyang CH
    Semin Thromb Hemost; 1985 Oct; 11(4):367-72. PubMed ID: 4071062
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of the anticoagulant action of phospholipase A purified from Trimeresurus mucrosquamatus (Formosan habu) snake venom.
    Ouyang C; Jy W; Zan YP; Teng CM
    Toxicon; 1981; 19(1):113-20. PubMed ID: 7222080
    [No Abstract]   [Full Text] [Related]  

  • 12. The basic phospholipase A2 from Naja nigricollis venom inhibits the prothrombinase complex by a novel nonenzymatic mechanism.
    Stefansson S; Kini RM; Evans HJ
    Biochemistry; 1990 Aug; 29(33):7742-6. PubMed ID: 2271532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anticoagulant effect of the human secretory phospholipase A2 on blood plasma and on a cell-free system is due to a phospholipid-independent mechanism of action involving the inhibition of factor Va.
    Mounier C; Franken PA; Verheij HM; Bon C
    Eur J Biochem; 1996 May; 237(3):778-85. PubMed ID: 8647125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anticoagulant activity of Malayan cobra (Naja naja sputatrix) venom and venom phospholipase A2 enzymes.
    Tan NH; Arunmozhiarasi A
    Biochem Int; 1989 Oct; 19(4):803-10. PubMed ID: 2619749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the anticoagulants from Taiwan cobra (Naja naja atra) snake venom.
    Teng CM; Kuo YP; Lee LG; Ouyang CH
    Toxicon; 1987; 25(2):201-10. PubMed ID: 3576637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipase A2 activity and substrate specificity of snake venom presynaptic toxins.
    Napias C; Heilbronn E
    Biochemistry; 1980 Mar; 19(6):1146-51. PubMed ID: 7370229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between the enzymatic activity, anticoagulant and antiplatelet effects of phospholipase A2 isoenzymes from Naja nigricollis venom.
    Kini RM; Evans HJ
    Thromb Haemost; 1988 Oct; 60(2):170-3. PubMed ID: 3146138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of methylation of histidine-48 on some enzymatic and pharmacological activities of snake venom phospholipases A2.
    Condrea E; Rapuano BE; Soons KR; Yang CC; Rosenberg P
    Life Sci; 1983 Mar; 32(13):1455-61. PubMed ID: 6834999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An acidic phospholipase A(2) (RVVA-PLA(2)-I) purified from Daboia russelli venom exerts its anticoagulant activity by enzymatic hydrolysis of plasma phospholipids and by non-enzymatic inhibition of factor Xa in a phospholipids/Ca(2+) independent manner.
    Saikia D; Thakur R; Mukherjee AK
    Toxicon; 2011 May; 57(6):841-50. PubMed ID: 21356226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phospholipase A2 with anticoagulant activity. II. Inhibition of the phospholiped activity in coagulation.
    Boffa MC; Boffa GA
    Biochim Biophys Acta; 1976 May; 429(3):839-52. PubMed ID: 5143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.